Study Title: A Phase II Study of FOLFOX combined with Nab-Paclitaxel (FOLFOX-A) in the Treatment of Metastatic or Advanced Unresectable Gastric, Gastro-Esophageal Junction Adenocarcinoma. Big Ten Cancer Research Consortium: BTCRC-GI15-015
- Closed to Accrual at:
- University of Illinois Cancer Center
- Holden Comprehensive Cancer Center, University of Iowa
- Michigan State University Breslin Cancer Center
- Masonic Cancer Center, University of Minnesota
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University
- Rutgers Cancer Institute of New Jersey
- University of Wisconsin Carbone Cancer Center
- Learn more:
- Publications and Presentations:
Study Contact: studies@hoosiercancer.org; (317) 921-2050.
Subscribe to the Big Ten CRC NewsletterXFacebookYouTube